# Lotemax SM

NDC: 24208-507
Generic name: loteprednol etabonate
Labeler / Manufacturer: Bausch & Lomb Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GEL
Routes: OPHTHALMIC
Marketing started: 20190225

FDA application: NDA208219

## Active ingredients

- LOTEPREDNOL ETABONATE: 3.8 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24208-507"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24208-507
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f9477b5-699f-4d3b-b9a6-0cc238266237